SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-138898
Filing Date
2024-05-15
Accepted
2024-05-15 07:45:32
Documents
15
Period of Report
2024-05-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d828339d8k.htm   iXBRL 8-K 33833
2 EX-99.1 d828339dex991.htm EX-99.1 21588
6 GRAPHIC g828339g0515015925469.jpg GRAPHIC 3511
  Complete submission text file 0001193125-24-138898.txt   192148

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vrca-20240514.xsd EX-101.SCH 2850
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vrca-20240514_lab.xml EX-101.LAB 17994
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vrca-20240514_pre.xml EX-101.PRE 11261
18 EXTRACTED XBRL INSTANCE DOCUMENT d828339d8k_htm.xml XML 3618
Mailing Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380
Business Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380 484-453-3300
Verrica Pharmaceuticals Inc. (Filer) CIK: 0001660334 (see all company filings)

IRS No.: 463137900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38529 | Film No.: 24947192
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)